268 related articles for article (PubMed ID: 1308923)
1. [Long-term treatment of central diabetes insipidus with oral DDAVP].
Carraro A; Fano M; Cuttica M; Bernareggi V; Giusti M; Giordano G
Minerva Endocrinol; 1992; 17(4):189-93. PubMed ID: 1308923
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of central diabetes insipidus using oral DDAVP. Comparison with intranasal treatment].
Carraro A; Fano M; Porcella E; Bernareggi V; Giusti M
Minerva Endocrinol; 1991; 16(3):141-5. PubMed ID: 1806811
[TBL] [Abstract][Full Text] [Related]
3. Central diabetes insipidus in children. Antidiuretic effect and pharmacokinetics of intranasal and peroral 1-deamino-8-D-arginine vasopressin.
Fjellestad-Paulsen A; Tubiana-Rufi N; Harris A; Czernichow P
Acta Endocrinol (Copenh); 1987 Jul; 115(3):307-12. PubMed ID: 3618082
[TBL] [Abstract][Full Text] [Related]
4. [Clinical evaluation of desmopressin (DDAVP) in diabetes insipidus: solution vs tablets].
Rampazzo AL; Boscaro M; Mantero F; Piccitto R
Minerva Endocrinol; 1992; 17(1):37-41. PubMed ID: 1495453
[TBL] [Abstract][Full Text] [Related]
5. Ten-year experience with DDAVP in treatment of diabetes insipidus.
Marek J; Loutocký A; Pacovský V; Zaoral M
Endokrinologie; 1978 May; 72(2):188-94. PubMed ID: 738214
[TBL] [Abstract][Full Text] [Related]
6. Effects of vasopressin analogues (DDAVP, DVDAVP) in the form of sublingual tablets in central diabetes insipidus.
Laczi F; Mezei G; Julesz J; Lázló FA
Int J Clin Pharmacol Ther Toxicol; 1981 Feb; 19(2):63-8. PubMed ID: 7216552
[TBL] [Abstract][Full Text] [Related]
7. DDAVP in the treatment of central diabetes insipidus.
Robinson AG
N Engl J Med; 1976 Mar; 294(10):507-11. PubMed ID: 1250255
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of 2 new formulations of desmopressin (DDAVP), nasal spray and tablets, in the therapy of diabetes insipidus].
Gelli D; Riolo A; Carioni E; Albano M
Minerva Endocrinol; 1989; 14(4):227-32. PubMed ID: 2636699
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, pharmacodynamics, long-term efficacy and safety of oral 1-deamino-8-D-arginine vasopressin in adult patients with central diabetes insipidus.
Lam KS; Wat MS; Choi KL; Ip TP; Pang RW; Kumana CR
Br J Clin Pharmacol; 1996 Sep; 42(3):379-85. PubMed ID: 8877030
[TBL] [Abstract][Full Text] [Related]
10. [Effectiveness of and tolerability to oral desmopressin in the treatment of central diabetes insipidus].
Merola B; Caruso E; De Chiara G; Rossi E; Longobardi S; Colao A; Brusco G; Lombardi G; Biraghi M
Minerva Med; 1992 Dec; 83(12):805-13. PubMed ID: 1491760
[TBL] [Abstract][Full Text] [Related]
11. Peroral treatment of diabetes insipidus with a polypeptide hormone analog, desmopressin.
Hammer M; Vilhardt H
J Pharmacol Exp Ther; 1985 Sep; 234(3):754-60. PubMed ID: 4032289
[TBL] [Abstract][Full Text] [Related]
12. [DDAVP in the treatment of acute neurosurgical diabetes insipidus].
Zancaner F; Griner A; Galante E
Minerva Med; 1984 Apr; 75(18):1063-7. PubMed ID: 6728257
[TBL] [Abstract][Full Text] [Related]
13. [Effects of vasopressin analogue DDAVP in patients with postoperative diabetes insipidus (author's transl)].
Kubota T; Kashiwara K; Ito H; Tani K; Yamamoto S
No To Shinkei; 1981 Jun; 33(3):617-23. PubMed ID: 7259900
[TBL] [Abstract][Full Text] [Related]
14. Effects of DDAVP in cranial diabetes insipidus as compared to other antidiuretic drugs.
Coculescu M; Antipa C; Cucu C
Endocrinologie; 1977; 15(4):275-81. PubMed ID: 563614
[TBL] [Abstract][Full Text] [Related]
15. Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin.
Czakó L; Mezei G; László FA
Acta Med Acad Sci Hung; 1975; 32(1):75-84. PubMed ID: 1233863
[TBL] [Abstract][Full Text] [Related]
16. The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.
Radó JP; Marosi J; Szende L; Borbély L; Takó J; Fischer J
Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):199-209. PubMed ID: 950263
[TBL] [Abstract][Full Text] [Related]
17. Treatment of central diabetes insipidus in adults and children with desmopressin.
Ziai F; Walter R; Rosenthal IM
Arch Intern Med; 1978 Sep; 138(9):1382-5. PubMed ID: 686929
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of diabetes insipidus].
Boscaro M; Mani E; Pistorello M; Rampazzo A
Minerva Endocrinol; 1990; 15(1):95-9. PubMed ID: 2274021
[TBL] [Abstract][Full Text] [Related]
19. Shortened duration of action of 1-deamino-8-D-arginine vasopressin (DDAVP) in patients with diabetes insipidus requiring high doses of peroral antidiuretic drugs.
Radó JP; Marosi J; Fischer J
J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):518-24. PubMed ID: 789414
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of the antidiuretic effects of Adiuretin-SD (DDAVP) and Pitressin Tannate in diabetes insipidus.
Czakó L; Julesz J; László FA
Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):10-3. PubMed ID: 631964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
